AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Roivant Sciences Ltd. Director's Dealing 2024

Dec 6, 2024

30587_dirs_2024-12-05_aeb9094e-ca2d-422a-a94a-402563c5f9ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Roivant Sciences Ltd. (ROIV)
CIK: 0001635088
Period of Report: 2024-12-03

Reporting Person: Sukhatme Mayukh (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-03	Common Shares	J	3651985	$12.205	Disposed	18836547	Direct

Footnotes

F1: Represents a transfer of Common Shares for estate planning purposes to a newly formed limited liability company with respect to which the reporting person does not have any voting or investment control.